Physician profile
Jay William Floyd
NPI 1861460313
$2,656.11
in general payments reported to CMS, 2019-2025
36 companies · $825 in 2025
The $825 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.20 · 2022: $55.37 · 2023: $774 · 2024: $925 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,504 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,504.32 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $323.75 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $291.10 | 2023-2025 | |
| Novo Nordisk INC | $186.01 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $183.25 | 2023-2025 | |
| Glaxosmithkline, LLC. | $144.50 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $131.15 | 2023-2025 | |
| Amgen INC. | $114.07 | 2024-2025 | Otezla, Repatha, Krystexxa |
| Boston Scientific Corporation | $101.27 | 2024-2025 | General - Pain Management |
| Exact Sciences Corporation | $92.92 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $92.02 | 2023-2025 | Freestyle Libre, Freestyle Libre 2 |
| Astellas Pharma US INC | $91.67 | 2024 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $88.00 | 2021-2023 | Rexulti, Nuedexta |
| Horizon Therapeutics Plc | $74.86 | 2022-2023 | Krystexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.77 | 2023-2025 | Xifaxan, Trulance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.96 | 2025 | Caplyta |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $52.23 | 2025 | Omnipod |
| Ardelyx, INC. | $47.66 | 2024-2025 | Ibsrela |
| Lilly USA, LLC | $47.01 | 2021-2024 | Mounjaro, Jardiance |
| Sanofi-Aventis U.S. LLC | $45.13 | 2024-2025 | |
| Medtronic, INC. | $40.37 | 2023-2024 | Intellis Adaptivestim, Venaseal |
| Janssen Pharmaceuticals, INC | $39.35 | 2023-2024 | Spravato |
| Novartis Pharmaceuticals Corporation | $37.50 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $34.82 | 2021-2025 | Austedo Xr |
| Saluda Medical Americas, INC. | $34.72 | 2025 | Evoke |
| Axsome Therapeutics, INC. | $30.98 | 2023 | Auvelity |
| Dexcom, INC. | $30.62 | 2024 | Dexcom G6 Transmitter |
| Spinal Simplicity, LLC | $24.33 | 2024 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $22.32 | 2025 | Prospera |
| Optinose US, INC. | $20.24 | 2024 | |
| Nevro Corp. | $19.38 | 2024 | Senza |
| Phathom Pharmaceuticals, INC. | $17.50 | 2024 | Voquezna |
| Lundbeck LLC | $16.97 | 2023 | Rexulti |
| Almatica Pharma LLC | $16.63 | 2024 | Teriparatide |
| Inspire Medical Systems, INC. | $13.49 | 2025 | Inspire |
| Viiv Healthcare Company | $13.35 | 2022 | |
| Neurelis, INC. | $13.21 | 2023 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.